{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:56:04Z","timestamp":1787021764721,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1014315","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000}}],"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021YFF0502900"],"award-info":[{"award-number":["2021YFF0502900"]}]},{"name":"Special Fund for Research on National Major Research Instruments of China","award":["62027824"],"award-info":[{"award-number":["62027824"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Growing evidence indicates that Folate Hydrolase 1 (FOLH1, also known as prostate-specific membrane antigen, PSMA) is aberrantly expressed across multiple malignancies, particularly showing significant upregulation in prostate cancer. However, systematic investigations into its pan-cancer expression patterns, immunomodulatory roles, and immune cell infiltration remain limited. The potential role of FOLH1 in prostate cancer is also not fully elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed FOLH1 mRNA expression, prognostic relevance, and immune infiltration across multiple malignancies, with a particular focus on prostate cancer. A machine learning (ML) workflow incorporating a deep learning model was developed to screen the therapeutic potential of drugs targeting FOLH1. The therapeutic potential of these candidates was validated through in vitro cellular assays and nude mouse xenograft models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      FOLH1 expression was significantly altered in 27 cancer types and showed cancer-specific immune correlations. Our AI platform identified melatonin as a computationally predicted FOLH1-interacting candidate.\n                      <jats:italic>In vitro<\/jats:italic>\n                      and\n                      <jats:italic>in vivo<\/jats:italic>\n                      experiments demonstrated that melatonin suppresses FOLH1 expression in a concentration-dependent manner, inhibits invasive and migratory capacities, and restricts tumor growth under physiological circadian melatonin levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights FOLH1\u2019s pan-cancer expression patterns and nominates melatonin as an exploratory therapeutic candidate for prostate cancer requiring further mechanistic validation. Our integrated computational-experimental framework highlights the promise of AI-driven drug discovery in oncology, while emphasizing the need for further mechanistic validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pcbi.1014315","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:42:17Z","timestamp":1779471737000},"page":"e1014315","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated computational and experimental analysis explores FOLH1 expression patterns across cancers and nominates melatonin as a potential modulator in prostate cancer models"],"prefix":"10.1371","volume":"22","author":[{"given":"Rui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2559-6686","authenticated-orcid":true,"given":"Xunbin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"3","key":"pcbi.1014315.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA: a cancer journal for clinicians"},{"key":"pcbi.1014315.ref002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2021.09.013","article-title":"Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A review","volume":"158","author":"M Larroquette","year":"2021","journal-title":"Eur J Cancer"},{"key":"pcbi.1014315.ref003","doi-asserted-by":"crossref","first-page":"108873","DOI":"10.1016\/j.clim.2021.108873","article-title":"Immune checkpoint inhibition for the treatment of cancers: an update and critical review of ongoing clinical trials","volume":"232","author":"H Akhbariyoon","year":"2021","journal-title":"Clinical Immunology"},{"key":"pcbi.1014315.ref004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-0716-2071-7_17","article-title":"A Method to Identify Potential Prognostic Markers Across Distinct Tumor Types","volume":"2445","author":"B Zhang","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"4","key":"pcbi.1014315.ref005","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/cells10040928","article-title":"Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed","volume":"10","author":"U Pfohl","year":"2021","journal-title":"Cells"},{"key":"pcbi.1014315.ref006","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3389\/fonc.2020.01030","article-title":"Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools","volume":"10","author":"G Nicora","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"pcbi.1014315.ref007","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"DA Silver","year":"1997","journal-title":"Clin Cancer Res"},{"issue":"12","key":"pcbi.1014315.ref008","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88634","article-title":"FOLH1\/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities","volume":"1","author":"R Rais","year":"2016","journal-title":"JCI Insight"},{"issue":"10","key":"pcbi.1014315.ref009","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3390\/cancers16101855","article-title":"Characterization of FOLH1 Expression in Renal Cell Carcinoma","volume":"16","author":"E Ovruchesky","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"pcbi.1014315.ref010","article-title":"Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma","volume":"1","author":"MK Ramirez-Fort","year":"2021","journal-title":"Skin Health Dis"},{"issue":"1","key":"pcbi.1014315.ref011","first-page":"102","article-title":"The expression and clinical significance of FOLR1 and PSMA in normal endometrium, atypical hyperplasia, and cancer tissues","volume":"32","author":"Z Xing","year":"2025","journal-title":"HANSHAO JIBING ZAZHI"},{"issue":"3","key":"pcbi.1014315.ref012","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2214\/AJR.20.23912","article-title":"Diagnostic Accuracy of 68Ga-PSMA PET\/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis","volume":"216","author":"S Satapathy","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"pcbi.1014315.ref013","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fonc.2018.00653","article-title":"New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen","volume":"8","author":"A Cimadamore","year":"2018","journal-title":"Front Oncol"},{"issue":"3","key":"pcbi.1014315.ref014","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ijrobp.2018.03.061","article-title":"Theragnostic target, prostate-specific membrane antigen\u2014also specific for nonprostatic malignancies","volume":"101","author":"MK Ramirez-Fort","year":"2018","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"1","key":"pcbi.1014315.ref015","doi-asserted-by":"crossref","first-page":"100917","DOI":"10.1016\/j.currproblcancer.2022.100917","article-title":"Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors","volume":"47","author":"O Young","year":"2023","journal-title":"Curr Probl Cancer"},{"key":"pcbi.1014315.ref016","doi-asserted-by":"crossref","first-page":"121802","DOI":"10.1016\/j.lfs.2023.121802","article-title":"Recent advances in using folate receptor 1 (FOLR1) for cancer diagnosis and treatment, with an emphasis on cancers that affect women","volume":"326","author":"P Varaganti","year":"2023","journal-title":"Life Sci"},{"issue":"10","key":"pcbi.1014315.ref017","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/ph15101292","article-title":"[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer","volume":"15","author":"U Hennrich","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"pcbi.1014315.ref018","doi-asserted-by":"crossref","first-page":"104946","DOI":"10.1016\/j.bioorg.2021.104946","article-title":"Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach","volume":"112","author":"A Rana","year":"2021","journal-title":"Bioorg Chem"},{"key":"pcbi.1014315.ref019","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-0716-1787-8_4","article-title":"Application of artificial intelligence and machine learning in drug discovery","volume":"2390","author":"RR Gupta","year":"2022","journal-title":"Methods Mol Biol"},{"key":"pcbi.1014315.ref020","doi-asserted-by":"crossref","first-page":"27978","DOI":"10.52202\/068431-2029","article-title":"ToDD: Topological Compound Fingerprinting in Computer-Aided Drug Discovery","author":"Y Chen","year":"2022","journal-title":"Advances in Neural Information Processing Systems 35"},{"key":"pcbi.1014315.ref021","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gr.2022.10.004","article-title":"Efficient time-variant reliability analysis of Bazimen landslide in the Three Gorges Reservoir Area using XGBoost and LightGBM algorithms","volume":"123","author":"W Zhang","year":"2023","journal-title":"Gondwana Research"},{"issue":"4","key":"pcbi.1014315.ref022","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s11030-023-10771-y","article-title":"Deep learning algorithms applied to computational chemistry","volume":"28","author":"A Guzman-Pando","year":"2024","journal-title":"Mol Divers"},{"issue":"1","key":"pcbi.1014315.ref023","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/foods14010127","article-title":"Bioinformatics and Deep Learning Approach to Discover Food-Derived Active Ingredients for Alzheimer\u2019s Disease Therapy","volume":"14","author":"J Zhou","year":"2025","journal-title":"Foods"},{"issue":"1","key":"pcbi.1014315.ref024","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41467-024-45566-8","article-title":"Transfer learning with graph neural networks for improved molecular property prediction in the multi-fidelity setting","volume":"15","author":"D Buterez","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"pcbi.1014315.ref025","doi-asserted-by":"crossref","first-page":"15626","DOI":"10.1038\/s41598-021-95128-x","article-title":"A stacking ensemble deep learning approach to cancer type classification based on TCGA data","volume":"11","author":"M Mohammed","year":"2021","journal-title":"Sci Rep"},{"key":"pcbi.1014315.ref026","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Y Han","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1014315.ref027","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/pro.3987","article-title":"The Human Protein Atlas-Spatial localization of the human proteome in health and disease","volume":"30","author":"A Digre","year":"2021","journal-title":"Protein Sci"},{"issue":"5","key":"pcbi.1014315.ref028","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/pharmaceutics15051359","article-title":"Using ChEMBL to Complement Schistosome Drug Discovery","volume":"15","author":"G Padalino","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"pcbi.1014315.ref029","article-title":"Exploring Chemical Information in PubChem","volume":"1","author":"S Kim","year":"2021","journal-title":"Curr Protoc"},{"issue":"7","key":"pcbi.1014315.ref030","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1021\/acs.jcim.5c00135","article-title":"Multitarget Natural Compounds for Ischemic Stroke Treatment: Integration of Deep Learning Prediction and Experimental Validation","volume":"65","author":"J Zhou","year":"2025","journal-title":"J Chem Inf Model"},{"key":"pcbi.1014315.ref031","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.csbj.2024.03.015","article-title":"Databases of ligand-binding pockets and protein-ligand interactions","volume":"23","author":"KA Carpenter","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"key":"pcbi.1014315.ref032","article-title":"BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data","volume":"53","author":"T Liu","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1014315.ref033","article-title":"PDBBind optimization to create a high-quality protein-ligand binding dataset for binding affinity prediction. arXiv preprint","author":"Y Wang","year":"2024"},{"issue":"4","key":"pcbi.1014315.ref034","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.fmre.2024.02.011","article-title":"A review of deep learning methods for ligand based drug virtual screening","volume":"4","author":"H Wu","year":"2024","journal-title":"Fundam Res"},{"issue":"12","key":"pcbi.1014315.ref035","doi-asserted-by":"crossref","first-page":"103373","DOI":"10.1016\/j.drudis.2022.103373","article-title":"Deep learning methods for molecular representation and property prediction","volume":"27","author":"Z Li","year":"2022","journal-title":"Drug Discov Today"},{"issue":"23","key":"pcbi.1014315.ref036","doi-asserted-by":"crossref","DOI":"10.1002\/qua.27230","article-title":"Predicting the multiple parameters of organic acceptors through machine learning using RDkit descriptors: An easy and fast pipeline","volume":"123","author":"KM Katubi","year":"2023","journal-title":"Int J of Quantum Chemistry"},{"issue":"1","key":"pcbi.1014315.ref037","article-title":"The Impact of Regularization on Linear Regression Based Model","volume":"1","author":"A Nwosu","year":"2024","journal-title":"Journal of Artificial Intelligence and Computer Science"},{"issue":"5","key":"pcbi.1014315.ref038","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/jmse11050903","article-title":"Parameter Prediction of the Non-Linear Nomoto Model for Different Ship Loading Conditions Using Support Vector Regression","volume":"11","author":"J Lan","year":"2023","journal-title":"JMSE"},{"key":"pcbi.1014315.ref039","doi-asserted-by":"crossref","first-page":"7001710","DOI":"10.1155\/2021\/7001710","article-title":"An extra tree regression model for discharge coefficient prediction: novel, practical applications in the hydraulic sector and future research directions","volume":"2021","author":"MM Hameed","year":"2021","journal-title":"Mathematical Problems in Engineering"},{"issue":"9","key":"pcbi.1014315.ref040","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/diagnostics11091714","article-title":"Diagnosis of Diabetes Mellitus Using Gradient Boosting Machine (LightGBM)","volume":"11","author":"DD Rufo","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"pcbi.1014315.ref041","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70172","article-title":"A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications","volume":"18","author":"M Wiens","year":"2025","journal-title":"Clin Transl Sci"},{"key":"pcbi.1014315.ref042","first-page":"4840","article-title":"Graph Neural Networks: Foundation, Frontiers and Applications","author":"L Wu","year":"2022","journal-title":"Proceedings of the 28th ACM SIGKDD Conference on Knowledge Discovery and Data Mining"},{"issue":"3","key":"pcbi.1014315.ref043","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/computation11030052","article-title":"Theoretical understanding of convolutional neural network: concepts, architectures, applications, future directions","volume":"11","author":"MM Taye","year":"2023","journal-title":"Computation"},{"issue":"1","key":"pcbi.1014315.ref044","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1038\/s41598-021-93070-6","article-title":"Random forest classification for predicting lifespan-extending chemical compounds","volume":"11","author":"S Kapsiani","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"pcbi.1014315.ref045","first-page":"277","article-title":"Comparative analysis of data visualization libraries Matplotlib and Seaborn in Python","volume":"10","author":"AH Sial","year":"2021","journal-title":"International Journal J"},{"issue":"10","key":"pcbi.1014315.ref046","doi-asserted-by":"crossref","first-page":"100588","DOI":"10.1016\/j.patter.2022.100588","article-title":"SELFIES and the future of molecular string representations","volume":"3","author":"M Krenn","year":"2022","journal-title":"Patterns (N Y)"},{"issue":"7","key":"pcbi.1014315.ref047","doi-asserted-by":"crossref","first-page":"2300056","DOI":"10.1002\/minf.202300056","article-title":"Exploring activity landscapes with extended similarity: is Tanimoto enough?","volume":"42","author":"TB Dunn","year":"2023","journal-title":"Molecular Informatics"},{"key":"pcbi.1014315.ref048","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"C Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"pcbi.1014315.ref049","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings","volume":"61","author":"J Eberhardt","year":"2021","journal-title":"Journal of Chemical Information and Modeling"},{"key":"pcbi.1014315.ref050","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac1077","article-title":"RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning","volume":"51","author":"SK Burley","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1014315.ref051","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"EF Pettersen","year":"2021","journal-title":"Protein Sci"},{"issue":"1","key":"pcbi.1014315.ref052","doi-asserted-by":"crossref","first-page":"50","DOI":"10.29303\/prospek.v4i1.328","article-title":"K-MEANS AND ELBOW METHOD FOR CLUSTER ANALYSIS OF ELEMENTARY SCHOOL DATA","volume":"4","author":"VA Permadi","year":"2023","journal-title":"PROSPEK"},{"issue":"04","key":"pcbi.1014315.ref053","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3991\/ijoe.v19i04.37059","article-title":"Determining the Optimal Number of Clusters using Silhouette Score as a Data Mining Technique","volume":"19","author":"Y Januzaj","year":"2023","journal-title":"Int J Onl Eng"},{"issue":"11","key":"pcbi.1014315.ref054","article-title":"Structure\u2013Activity Relationship in Microstructure Design for Electromagnetic Wave Absorption Applications","volume":"4","author":"J Du","year":"2023","journal-title":"Small Structures"},{"issue":"1","key":"pcbi.1014315.ref055","first-page":"6","article-title":"More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET\/CT","volume":"22","author":"NK Pianou","year":"2019","journal-title":"Hell J Nucl Med"},{"issue":"4","key":"pcbi.1014315.ref056","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2967\/jnumed.118.219352","article-title":"Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes","volume":"60","author":"J Violet","year":"2019","journal-title":"J Nucl Med"},{"issue":"23","key":"pcbi.1014315.ref057","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.7150\/thno.36739","article-title":"PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery","volume":"9","author":"YHW Derks","year":"2019","journal-title":"Theranostics"},{"key":"pcbi.1014315.ref058","doi-asserted-by":"crossref","unstructured":"Ahmadzadehfar H, Seifert R, Afshar-Oromieh A, et al. Prostate Cancer Theranostics With (177)Lu-PSMA. Semin Nucl MedJ. 2024;54 4:581\u201390.","DOI":"10.1053\/j.semnuclmed.2024.02.007"},{"issue":"8","key":"pcbi.1014315.ref059","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10585-018-9878-x","article-title":"Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases","volume":"34","author":"M Kasoha","year":"2017","journal-title":"Clin Exp Metastasis"},{"issue":"12","key":"pcbi.1014315.ref060","first-page":"3536","article-title":"PSMA Expression in Differentiated Thyroid Cancer: Association With Radioiodine, 18FDG Uptake, and Patient Outcome","volume":"106","author":"R Ciappuccini","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"pcbi.1014315.ref061","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.humpath.2006.11.012","article-title":"Prostate-specific membrane antigen expression as a predictor of prostate cancer progression","volume":"38","author":"S Perner","year":"2007","journal-title":"Hum Pathol"},{"key":"pcbi.1014315.ref062","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"MS Rooney","year":"2015","journal-title":"Cell"},{"issue":"2","key":"pcbi.1014315.ref063","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4049\/jimmunol.177.2.896","article-title":"Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells","volume":"177","author":"AG Jarnicki","year":"2006","journal-title":"J Immunol"},{"issue":"5","key":"pcbi.1014315.ref064","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/ph14050437","article-title":"Considerations to Be Taken When Carrying Out Medicinal Plant Research-What We Learn from an Insight into the IC50 Values, Bioavailability and Clinical Efficacy of Exemplary Anti-Inflammatory Herbal Components","volume":"14","author":"M Abdel-Tawab","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"pcbi.1014315.ref065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025710119","article-title":"Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells","volume":"119","author":"MK Bakht","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pcbi.1014315.ref066","doi-asserted-by":"crossref","first-page":"840","DOI":"10.14336\/AD.2022.1010","article-title":"Melatonin and Prostate Cancer: Anti-tumor Roles and Therapeutic Application","volume":"14","author":"MF Megerian","year":"2023","journal-title":"Aging Dis"},{"issue":"4","key":"pcbi.1014315.ref067","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1574892818666230419081414","article-title":"Co-delivery of Siape1 and melatonin by (125)I-loaded PSMA-targeted nanoparticles for the treatment of prostate cancer","volume":"19","author":"Y Liu","year":"2024","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"pcbi.1014315.ref068","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/1538-7445.AM2022-222","article-title":"Abstract 222: Exposure to dim light at night disrupts the nocturnal melatonin signal in male nude rats bearing tissue-isolated castration-sensitive VCaP human prostate cancer: Impact on tumor circadian dynamics of the Warburg effect, lipid signaling and proliferation","volume":"82","author":"EM Dauchy","year":"2022","journal-title":"Cancer Research"},{"issue":"12","key":"pcbi.1014315.ref069","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s41591-018-0271-8","article-title":"The emerging link between cancer, metabolism, and circadian rhythms","volume":"24","author":"S Masri","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"pcbi.1014315.ref070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/aja202255","article-title":"Circadian rhythm in prostate cancer: time to take notice of the clock","volume":"25","author":"W-Z Zhu","year":"2023","journal-title":"Asian J Androl"},{"issue":"5","key":"pcbi.1014315.ref071","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ijc.29400","article-title":"Night shift work, chronotype and prostate cancer risk in the MCC-Spain case-control study","volume":"137","author":"K Papantoniou","year":"2015","journal-title":"Int J Cancer"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1014315","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T17:46:40Z","timestamp":1779990400000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014315"}},"subtitle":[],"editor":[{"given":"Ilya","family":"Ioshikhes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":71,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1014315","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}